Please use this identifier to cite or link to this item:
Title: Inotuzumab ozogamicin resistance associated with a novel CD22 truncating mutation in a case of B-acute lymphoblastic leukaemia.
Austin Authors: Ryland, Georgina L;Barraclough, Allison ;Fong, Chun Yew ;Fleming, Shaun;Bajel, Ashish;Hofmann, Oliver;Westerman, David;Grimmond, Sean;Blombery, Piers
Affiliation: Department of Clinical Haematology, Alfred Hospital, Melbourne, VIC, Australia
Department of Clinical Haematology, Austin Health, Heidelberg, Victoria, Australia
Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
Centre for Cancer Research, University of Melbourne, Melbourne, VIC, Australia
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia
Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia
Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia
Issue Date: Oct-2020
Date: 2020-07-09
Publication information: British Journal of Haematology 2020; 191(1): 123-126
DOI: 10.1111/bjh.16949
ORCID: 0000-0002-4990-0961
Journal: British journal of haematology
PubMed URL: 32648276
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Sep 27, 2023

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.